Summary of Significant Accounting Policies (Tables)
|
12 Months Ended |
Jun. 30, 2026 |
| Summary of Significant Accounting Policies |
|
| Schedule of vendor concentration risk percentage |
| | | | | | | | | Year Ended | | | | June 30, | | | | 2026 | | | 2025 | | Vendor A | | 28 | % | | 27 | % | Vendor B | | 11 | % | | 10 | % |
|
| Schedule of revenue by geographical region |
| | | | | | | | | | | | | | | Year Ended | | | | June 30, | | | | 2026 | | | 2025 | | United States | | $ | 27,231,305 | | 56.4 | % | | $ | 28,213,701 | | 57.5 | % | Europe | | | 15,942,672 | | 33.0 | % | | | 15,689,693 | | 32.0 | % | Rest of World | | | 5,132,980 | | 10.6 | % | | | 5,154,587 | | 10.5 | % | Total | | $ | 48,306,957 | | 100 | % | | $ | 49,057,981 | | 100 | % |
|
| Schedule of accounts receivable net by geographical region |
| | | | | | | | | | | | | | | Year Ended | | | | June 30, | | | | 2026 | | | 2025 | | United States | | $ | 3,822,084 | | 54.9 | % | | $ | 4,033,807 | | 56.1 | % | Europe | | | 2,226,167 | | 32.0 | % | | | 2,413,906 | | 33.6 | % | Rest of World | | | 914,789 | | 13.1 | % | | | 743,521 | | 10.3 | % | Total | | $ | 6,963,040 | | 100 | % | | $ | 7,191,234 | | 100 | % |
|
| Schedule of segment reporting information |
| | | | | | | | | Year ended June 30, | | | 2026 | | 2025 | Revenue | | $ | 48,306,957 | | $ | 49,057,981 | Cost of revenue | | | 23,236,449 | | | 24,862,030 | Gross profit | | | 25,070,508 | | | 24,195,951 | Gross profit margin | | | 51.9% | | | 49.3% | Selling, general and administrative expenses: | | | | | | | Sales and marketing | | | 6,397,899 | | | 5,360,356 | Technology and product development | | | 6,121,647 | | | 5,631,344 | General and administrative | | | 6,724,399 | | | 7,936,644 | Stock-based compensation expense | | | 928,516 | | | 1,723,561 | Foreign currency transaction loss (gain) | | | 54,697 | | | (202,527) | Total selling, general and administrative expenses | | | 20,227,158 | | | 20,449,378 | Depreciation and amortization | | | 1,254,973 | | | 1,245,362 | Net income | | $ | 2,822,068 | | $ | 1,265,553 |
| | | | | | | | | Year ended June 30, | | | 2026 | | 2025 | Cash and cash equivalents | | $ | 12,630,283 | | $ | 12,227,312 | Current assets, excluding cash and cash equivalents | | | 8,063,885 | | | 7,772,416 | Long term assets | | | 24,970,550 | | | 26,120,946 | Total segment assets | | $ | 45,664,718 | | $ | 46,120,674 |
|
| Schedule of basic and diluted earnings per share |
| | | | | | | | | | | Years Ended | | | | June 30, | | | | 2026 | | 2025 | Net income available to common shareholders | | | $ | 2,822,068 | | $ | 1,265,553 | | | | | | | | | Weighted average commons shares - basic | | | | 31,788,992 | | | 30,681,187 | Dilutive effect of outstanding stock options | | | | 465,981 | | | 822,785 | Dilutive effect of unvested restricted common stock | | | | 17,862 | | | — | Weighted average commons shares - diluted | | | | 32,272,835 | | | 31,503,972 | | | | | | | | | Net income per common share: | | | | | | | | Basic | | | $ | 0.09 | | $ | 0.04 | Diluted | | | $ | 0.09 | | $ | 0.04 |
|
| Schedule of Company's assets and liabilities at fair value |
| | | | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, 2026 | | As of June 30, 2025 | | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | | | | | | | | | | | | | | | | | | | | | | | | | Assets | | | | | | | | | | | | | | | | | | | | | | | | | Total assets | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities | | | | | | | | | | | | | | | | | | | | | | | | | Contingent earnout liability | | $ | — | | | — | | $ | 7,323,314 | | $ | 7,323,314 | | $ | — | | | — | | $ | 14,046,640 | | $ | 14,046,640 | Total liabilities | | $ | — | | $ | — | | $ | 7,323,314 | | $ | 7,323,314 | | $ | — | | $ | — | | $ | 14,046,640 | | $ | 14,046,640 |
|
| Schedule of company's contingent earnout liability activity |
| | | | | | | | | Years Ended | | | June 30, | | | 2026 | | 2025 | Beginning balance, contingent earnout liability | | $ | 14,046,640 | | $ | 12,298,114 | | | | | | | | Change in fair value of contingent earnout liability | | | — | | | 1,748,526 | Accreted interest expense | | | 1,040,293 | | | — | Scite earnout payments in cash | | | (4,856,763) | | | — | Scite earnout payments in shares of common stock | | | (2,906,856) | | | — | Ending balance, contingent earnout liability | | $ | 7,323,314 | | $ | 14,046,640 | | | | | | | |
|